FDA Will Reopen CBD Public Hearing Docket To Get More Data

FDA plans to reopen the public docket for its May 2019 cannabidiol hearing so that stakeholders can share relevant data on CBD, agency chief Stephen Hahn said in a Thursday (March 5) press release, which provided an overview of FDA’s current work in the area. The press release provides much of the same information as FDA’s CBD regulatory report, which the agency recently sent to Congress. The push for additional public comment is part of FDA’s attempt to address data...